[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349257-105":59,"doc-detail-349257-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","snornas-and-their-derived-sdrnas-emerging-regulators-biomarkers-and-therapeutic-targets-in-human-cancers-review","snoRNAs and their derived sdRNAs: Emerging regulators, biomarkers, and therapeutic targets in human cancers - Review","","Small nucleolar RNAs (snoRNAs) are conserved non-coding RNAs that guide 2'-O-methylation and pseudouridylation of ribosomal RNA and have been implicated in diverse cellular functions and human cancer. This review summarizes snoRNA biogenesis, classification, and modification mechanisms, emphasizing non-canonical roles in mRNA splicing, stability, and protein interactions. It links snoRNA dysregulation to key oncogenic processes, evaluates sdRNAs, and discusses liquid-biopsy biomarker potential and therapeutic targeting via antisense oligonucleotides and small molecules.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/snornas-and-their-derived-sdrnas-emerging-regulators-biomarkers-and-therapeutic-targets-in-human-cancers-review/349257/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/snornas-and-their-derived-sdrnas-emerging-regulators-biomarkers-and-therapeutic-targets-in-human-cancers-review/349257.png","ImageObject",300,407,{"name":92,"@type":93},"supergirl","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What are snoRNAs and what do they primarily do?","Question",{"text":113,"@type":114},"SnoRNAs are conserved non-coding RNAs that guide 2'-O-methylation and pseudouridylation of ribosomal RNA. They also function in ribonucleoprotein complexes to precisely target specific cellular RNAs.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How are sdRNAs generated from snoRNAs?",{"text":118,"@type":114},"SnoRNAs can be processed into smaller fragments of 16 to 36 nucleotides called snoRNA-derived fragments (sdRNAs). SdRNAs were first identified in 2008 and represent a relatively unexplored regulatory ncRNA class.",{"name":120,"@type":111,"acceptedAnswer":121},"How can snoRNAs and sdRNAs be used in cancer diagnosis, prognosis, and therapy?",{"text":122,"@type":114},"The review examines their emerging potential as diagnostic and prognostic biomarkers detectable in liquid biopsies. It also highlights therapeutic promise as targets for antisense oligonucleotides and small-molecule intervention.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349257,1790306040,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","INTERNATIONAL JOURNAL OF ONCOLOGY 69: 80, 2026  \nsnoRNAs and their derived sdRNAs: Emerging regulators, biomarkers, and therapeutic targets in human cancers (Review)  \nJIAHUI MAO 1 , HAO LIN2 , FENG GU3 and ZHAOJI PAN3  \n1Department of Central Laboratory, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212008, P.R. China; 2Department of Gastrointestinal Surgery, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu 221009, P.R. China;  \n3  \nDepartment of Clinical Laboratory, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu 221009, P.R. China  \nReceived February 6, 2026; Accepted April 8, 2026  \nDOI: 10.3892/ijo.2026.5893  \nAbstract. Small nucleolar RNAs (snoRNAs) are a conserved class of non‑coding RNAs that guide 2'‑O‑methylation and pseudouridylation of ribosomal RNA. First identified over five decades ago, snoRNAs have emerged as critical regula‑ tors of cellular function, with high‑throughput sequencing revealing their dysregulation in numerous human diseases, particularly cancer. In the present review, the biogenesis, classification, and modification mechanisms of snoRNAsand snoRNA‑derived fragments (sdRNAs) are compre‑ hensively summarized. Recent advances in understanding their non‑canonical functions are highlighted, which extend beyond ribosomal RNA modification to include regula‑ tion of mRNA splicing, stability, and protein interactions . These diverse mechanisms enable snoRNAs to influence key cancer‑related processes such as proliferation, metas‑ tasis, metabolic reprogramming, and therapy resistance. A comprehensive overview of snoRNA dysregulation across major cancer types is provided, including colorectal, hepa‑ tocellular, gastric, lung, breast, and ovarian cancers, with a detailed discussion of underlying molecular pathways . Furthermore, their emerging potential as diagnostic and prognostic biomarkers detectable in liquid biopsies is examined, as well as their promise as therapeutic targets amenable to antisense oligonucleotide and small molecule intervention . The present review integrates current knowl‑ edge of snoRNA/sdRNA biology and highlights critical gaps and future directions, providing a foundation for translating these regulatory RNAs into clinical oncology applications .  \nCorrespondence to: Dr Zhaoji Pan or Dr Feng Gu, Department of Clinical Laboratory, Xuzhou Central Hospital, Southeast University, 199 Jiefang South Road, Xuzhou, Jiangsu 221009, P.R. China  \nE‑mail: [1169479680@qq.com](1169479680@qq.com)  \nE‑mail: [15852482679@126.com](15852482679@126.com)  \nKey words: small nucleolar RNAs, small nucleolar RNA‑derived fragments, cancer biomarker, therapeutic target, tumor microenvironment  \nContents  \n1. Introduction  \n2. Biogenesis  \n3. snoRNA classes and functions  \n4. sdRNAs: Biogenesis and functions  \n5. Biological roles of snoRNAs in cancer  \n6. sdRNAs in cancer  \n7. Extracellular snoRNAs for cancer diagnosis and prognosis  \n8. snoRNA‑targeting tools  \n9. Discussion  \n10. Conclusion  \n1. Introduction  \nFirst identified in mammalian cells in 1960, snoRNAs are recognized as pivotal, naturally occurring guide RNAs . Typically ranging from 60 to 300 nucleotides in length, they function within ribonucleoprotein (RNP) complexes to precisely target specific cellular RNAs . While the human genome harbors over 1,000 annotated snoRNA genes, a striking 80% of these remain functionally enigmatic (1,2) .  \nAccumulating evidence indicates that specific snoRNAs exert direct control over gene expression by governing mRNA stability, editing, and splicing‑mechanisms that may operate autonomously from canonical RNA modification path‑ ways (3,4) . Notably, >50 snoRNAs have been implicated indysregulation across over 12 cancer types, although the precise mechanisms underlying disease pathogenesis due to snoRNAs deletions or mutations are still largely elusive, primarily owing to limitations in current methodologies for comprehensive identification of snoRNA targets and t","cbCaiuIEXI18598F","https://ap.wps.com/l/cbCaiuIEXI18598F","pdf",1791721,"English","# Introduction\n# Biogenesis\n# snoRNA classes and functions\n# sdRNAs: Biogenesis and functions\n# Biological roles of snoRNAs in cancer\n# sdRNAs in cancer\n# Extracellular snoRNAs for cancer diagnosis and prognosis\n# snoRNA-targeting tools\n# Discussion\n# Conclusion","[{\"question\":\"What are snoRNAs and what do they primarily do?\",\"answer\":\"SnoRNAs are conserved non-coding RNAs that guide 2'-O-methylation and pseudouridylation of ribosomal RNA. They also function in ribonucleoprotein complexes to precisely target specific cellular RNAs.\"},{\"question\":\"How are sdRNAs generated from snoRNAs?\",\"answer\":\"SnoRNAs can be processed into smaller fragments of 16 to 36 nucleotides called snoRNA-derived fragments (sdRNAs). SdRNAs were first identified in 2008 and represent a relatively unexplored regulatory ncRNA class.\"},{\"question\":\"How can snoRNAs and sdRNAs be used in cancer diagnosis, prognosis, and therapy?\",\"answer\":\"The review examines their emerging potential as diagnostic and prognostic biomarkers detectable in liquid biopsies. It also highlights therapeutic promise as targets for antisense oligonucleotides and small-molecule intervention.\"}]","snoRNAs and their derived sdRNAs: Emerging regulators, biomarkers, and therapeutic targets in human cancers - Review | PDF",1790082469,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e1b5baff45d3202e4f1ff155c6da854.webp",983,1357,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2826a41880db4dbd009927b9765d596.webp",982,1356,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1f29d1daf9a3584ea2a4c5031b3950f.webp",981,1354,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4fe1146968cd2f2f6876e6e3505a58f.webp",980,1353]